Geneus SAS (registered as Geneus Biotech SAS; brand Geneus®)
LiquidBlackout / LiquidVector biodefense and biointrusion systems, restricted to authorised government buyers.
Paris, France
1-10
Vitality Radar
42
Current
6M History
Industry
Updated 17 days ago
Pillar Analysis
Presence
46
Digital footprint, brand visibility, and online reach across channels
Business
41
Revenue signals, funding status, partnerships, and market traction
Innovation
58
R&D activity, patents, product launches, and technology adoption
Pulse
32
Recent momentum — hiring trends, news mentions, and social engagement
Capacity
35
Team strength, leadership depth, and organizational scale
Strategic Assessment
Strategic Vector
Geneus SAS positions itself as a deep-tech biomaterials and genomics player in Paris, focusing on IP-protected cell-based fur, wool, and related LiquidSeries technologies with emerging biodefense-relevant capabilities.
Efficiency Ratio
Given its very small team size and visible IP and brand footprint, Geneus appears moderately efficient in converting limited resources into differentiated technology but shows limited commercial and organizational scaling signals.
Evidence Signals
No dated public events found. The pillar scores above rest on the analyst assessment alone.
- About
- Geneus SAS, registered as Geneus Biotech SAS in the 7th arrondissement of Paris with EUR 50,000 share capital, markets LiquidBlackout and LiquidVector as a biodefense and biointrusion system, available only to authorised government, military and law-enforcement customers subject to export-control screening. Everything known comes from the company's own pages; the gap between the scale of the claim and the size of the entity is the reason to verify before relying on this record.
- Relevancy
- Its own product page carries a named, dedicated defense product line (LiquidBlackout / LiquidVector, a 'biodefense/biointrusion system') with access restricted to authorised government/military/law-enforcement customers including export-control screening. More than an application-list mention (not a pure EPIGAP case) but resting exclusively on self-presentation. Anchor A2 (self-declaration only). Classified C12-08.
- Tags
- #Biodefense #CBRN #Biointrusion #LiquidBlackout #ExportControlled #GatedProduct #France